GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for urokinase-type plasminogen activator (Q8MHY7)

Analyse AlphaFold monomer V2.0 prediction for urokinase-type plasminogen activator… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q8MHY7
Type
protein
Length
433 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x4Ef77Afb5a3D9F41c95Be3227D1CC986CCb61835
Molecule
Urokinase-type plasminogen activator
UniProt
Q8MHY7
Pockets
7 · best druggability 0.53

Structure

1 distinct chain · 7% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activatorprotein4337% helix, 30% strandQ8MHY7

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11050.530.8322empty
2800.510.8421empty
31310.420.7629empty
41310.390.7419empty
5830.340.7419empty

Modifications

Observed in the structure: 12 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.